Patent 7247473 was granted and assigned to Cytokinetics on July, 2007 by the United States Patent and Trademark Office.
The invention provides isolated nucleic acid and amino acid sequences of HsKip3, antibodies to HsKip3, methods of screening for HsKip3a modulators using biologically active HsKip3, and kits for screening for HsKip3a modulators.